Lyka Labs Ltd.

Financial

	Lyka Labs	Zim Laboratories	Medico Remedies
Operational Metrics
Financials
5 yr Average ROE	62.44 %	7.41 %	13.93 %
5yr average Equity Multiplier	2.9	1.88	2.07
5yr Average Asset Turnover Ratio	0.73	0.94	1.49
5yr Avg Net Profit Margin	-0.79 %	4.15 %	4.73 %
Price to Book	3.44	1.46	5.46
P/E	47.45	39.17	33.01
5yr Avg Cash Conversion Cycle	32.55 Days	37.07 Days	53.33 Days
Inventory Days	24.2 Days	68.72 Days	48.95 Days
Days Receivable	92.33 Days	99.71 Days	129.15 Days
Days Payable	106.74 Days	143.26 Days	124.28 Days
5yr Average Interest Coverage Ratio	2.2	3.96	11.55
5yr Avg ROCE	25.83 %	13.52 %	20.03 %
5yr Avg Operating Profit Margin	24.02 %	12.21 %	7.11 %
5 yr average Debt to Equity	1.25	0.39	0.26
5yr CAGR Net Profit	n/a	10.7 %	31.26 %
5yr Average Return on Assets	1.72 %	4.02 %	6.88 %
Shareholdings
Promoter Holding	58.16 %	33.26 %	62.59 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	10.36 %	0.0	-10.75 %
Change in Mutual Fund Holding (3 Yrs)	-3.53 %	0.0	0.0

Business

	Lyka Labs	Zim Laboratories	Medico Remedies
Product Wise Break-Up	Product Wise Break-Up Formulations 96.8 Bulk Drugs 3.2 Pharma 0 Traded Goods 0 Manufactured Goods 0	Product Wise Break-Up Pharmaceutical 100.0 Bulk Drugs 0 Traded Goods 0 Formulations 0 Manufactured Goods 0	Product Wise Break-Up Pharma 0 Bulk Drugs 0 Traded Goods 1.96 Formulations 0 Manufactured Goods 96.53 Others 1.51
Location Wise Break-Up	Location Wise Break-Up India 63.48 International 36.52 MENA 0 Asia (Ex India) 0 Africa 0 India 0 Outside India 0	Location Wise Break-Up Africa 9.0 India 17.0 Asia (Ex India) 25.0 International 0 Outside India 0 Middle East 39.0 Others 10.0	Location Wise Break-Up Africa 0 India 14.26 Asia (Ex India) 0 International 0 Outside India 85.74 MENA 0